Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response
Clinical trial NCT01167244 · COMPLETED
Trial details
- NCT number
- NCT01167244
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-04-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.